ArticleFrontiers in insect science2022
Fall armyworm from a maize multi-peril pest risk perspective.
Article in Frontiers in insect science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 23 citations in OpenAlex.
- Future Range Shifts in Major Maize Insect Pests Suggest Their Increasing Impacts on Global Maize Production.Insects · 2025Article
- Migration extent and potential economic impact of the fall armyworm in Europe.Scientific reports · 2025Article
- Validating Indigenous Farmers' Practice in the Management of the Fall ArmywormLife (Basel, Switzerland) · 2024Article
- Article
- Genetic engineering and genome editing technologies as catalyst for Africa's food security: the case of plant biotechnology in Nigeria.Frontiers in genome editing · 2024Review
- Article
- Hybrid breeding for fall armyworm resistance: Combining ability and hybrid prediction.Plant breeding = Zeitschrift fur Pflanzenzuchtung · 2023Article
- Migration risk of fall armyworm (Frontiers in plant science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We assembled 3,175 geo-tagged occurrences of fall armyworm worldwide and used that data in conjunction with information about the physiological requirements of the pest to spatially assess its global climate suitability. Our analysis indicates that almost the entire African maize crop is grown in areas with climates that support seasonal infestations of the insect, while almost 92% of the maize area supports year-round growth of the pest. In contrast, rich-country maize production largely occurs in temperate areas where only 2.3% of the area may allow the pest to survive year-round, although still subject to worrisome seasonal risks. This means the African maize crop is especially susceptible to damaging infestation from fall armyworm, on par with the risk exposure to this pest faced by maize producers throughout Latin America. We show that the maize grown in Africa is also especially vulnerable to infestations from a host of other crop pests. Our multi-peril pest risk study reveals that over 95% of the African maize area deemed climate suitable for fall armyworm, can also support year-round survival of at least three or more pests. The spatial concurrence of climatically suitable locations for these pests raises the production risk for farmers well above the risks posed from fall armyworm alone. Starkly, over half (52.5%) of the African maize area deemed suitable for fall armyworm is also at risk from a further nine pests, while over a third (38.1%) of the area is susceptible to an additional 10 pests. This constitutes an exceptionally risky production environment for African maize producers, with substantive and complex implications for developing and implementing crop breeding, biological, chemical and other crop management strategies to help mitigate these multi-peril risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.